P1315: THE CHRONOLOGICAL SEQUENCE OF 12 GY TOTAL BODY IRRADIATION AND CYCLOPHOSPHAMIDE CONDITIONING DOES NOT IMPACT OUTCOMES IN AML PATIENTS UNDERGOING MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION

Ähnliche Einträge

• Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
  von: Madlen Jentzsch, et al.
  Veröffentlicht: (2022-12-01)
• P497: CLINICAL OUTCOMES OF NPM1-MUTATED ACUTE MYELOID LEUKEMIA (AML) PATIENTS WITH MEASURABLE RESIDUAL DISEASE (MRD) RELAPSE AFTER ACHIEVEMENT OF A FIRST MRD-NEGATIVE REMISSION
  von: Madlen Jentzsch, et al.
  Veröffentlicht: (2023-08-01)
• PB2450: SEX-ASSOCIATED OUTCOME DIFFERENCES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
  von: Jule Ussmann, et al.
  Veröffentlicht: (2023-08-01)
• P1315: THE CHRONOLOGICAL SEQUENCE OF 12 GY TOTAL BODY IRRADIATION AND CYCLOPHOSPHAMIDE CONDITIONING DOES NOT IMPACT OUTCOMES IN AML PATIENTS UNDERGOING MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION
  von: Georg-Nikolaus Franke, et al.
  Veröffentlicht: (2023-08-01)
• Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?
  von: Sebastian Schwind, et al.
  Veröffentlicht: (2024-03-01)